Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Walenga

Showing results (51-60 of 196) with videos related to

Pageof 20
Sort By:
Seminars in Thrombosis and Hemostasis|April 1, 1985
Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractionsJ M Walenga, L Bara, M M Samama, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
A new approach in monitoring recombinant hirudin during cardiopulmonary bypassM J Koza, J M Walenga, J Fareed, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1984
Development of fibrinopeptide A generation tests in the evaluation and the monitoring of the action of heparin and its low molecular weight fractionsR M Emanuele, J Fareed, D Hoppensteadt, et al.
The Annals of Thoracic Surgery|March 1, 1993
Effects of aprotinin on anticoagulant monitoring: implications in cardiovascular surgeryD M Najman, J M Walenga, J Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Heparin-induced thrombocytopenic potential of GAG and non-GAG-based antithrombotic agentsW P Jeske, A M Jay, S Haas, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1983
Automated clot-based methods in coagulation testing: current and future considerationsJ M Walenga, D Hoppensteadt, J Fareed, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Pharmacodynamics of a sulfated lactobionic acid amide-derived antithrombotic agent (Aprosulate) in primatesJ Fareed, S Coker, O Iqbal, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1984
Molecular markers of hemostatic activation: future perspectivesJ Fareed, W H Baker, J M Walenga, et al.
The Journal of Burn Care & Rehabilitation|February 7, 2001
Antithrombin(H) concentrate infusions are safe and effective in patients with thermal injuriesA Kowal-Vern, V McGill, J M Walenga, et al.
Haemostasis|January 1, 1988
Comparative study on the in vitro and in vivo activities of seven low-molecular-weight heparinsJ Fareed, J M Walenga, D Hoppensteadt, et al.
Pageof 20

Showing results (51-60 of 196) with videos related to

Sort By:
Pageof 20
Seminars in Thrombosis and Hemostasis|April 1, 1985
Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractionsJ M Walenga, L Bara, M M Samama, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
A new approach in monitoring recombinant hirudin during cardiopulmonary bypassM J Koza, J M Walenga, J Fareed, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1984
Development of fibrinopeptide A generation tests in the evaluation and the monitoring of the action of heparin and its low molecular weight fractionsR M Emanuele, J Fareed, D Hoppensteadt, et al.
The Annals of Thoracic Surgery|March 1, 1993
Effects of aprotinin on anticoagulant monitoring: implications in cardiovascular surgeryD M Najman, J M Walenga, J Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Heparin-induced thrombocytopenic potential of GAG and non-GAG-based antithrombotic agentsW P Jeske, A M Jay, S Haas, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1983
Automated clot-based methods in coagulation testing: current and future considerationsJ M Walenga, D Hoppensteadt, J Fareed, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Pharmacodynamics of a sulfated lactobionic acid amide-derived antithrombotic agent (Aprosulate) in primatesJ Fareed, S Coker, O Iqbal, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1984
Molecular markers of hemostatic activation: future perspectivesJ Fareed, W H Baker, J M Walenga, et al.
The Journal of Burn Care & Rehabilitation|February 7, 2001
Antithrombin(H) concentrate infusions are safe and effective in patients with thermal injuriesA Kowal-Vern, V McGill, J M Walenga, et al.
Haemostasis|January 1, 1988
Comparative study on the in vitro and in vivo activities of seven low-molecular-weight heparinsJ Fareed, J M Walenga, D Hoppensteadt, et al.
Pageof 20